Table 2. Subgroup analysis of the correlation between TNFR2 expression and OS in patients with cancer.
| Subgroup | Number of studies | Number of patients | Pooled HR (95% CI) | P value | Heterogeneity | |
|---|---|---|---|---|---|---|
| I2 (%) | P value | |||||
| Cancer type | ||||||
| Solid cancer | 6 | 1,848 | 1.50 (1.21–1.87) | <0.001 | 45.1 | 0.11 |
| Lymphoma | 3 | 381 | 2.95 (1.85–4.69) | <0.001 | 0.0 | 0.45 |
| TNFR2 detected sample | ||||||
| Tissue | 4 | 1,216 | 1.72 (1.41–2.11) | <0.001 | 0.0 | 0.73 |
| Serum | 5 | 1,013 | 1.88 (1.19–2.98) | 0.007 | 73.9 | 0.004 |
TNFR2, tissue necrosis factor receptor 2; OS, overall survival; HR, hazard ratio; CI, confidence interval.